| Zioptan (tafluprost) / Santen, Merck (MSD) |
24hr study, ChiCTR-ONC-14004780: A Study on the 24-hour Intraocular Pressure Profile of the 0.0015% Tafluprost Ophthalmic Solution in Patients with Primary Open Angle Glaucoma, Primary Angle Closure Glaucoma or Ocular Hypertension |
|
|
| Recruiting | 4 | 15 | | Colorless clear 0.0015% aqueous ophthalmic solution containing 15 μg of tafluprost in 1 ml One drop is instilled to the affected eye(s), once daily (same as the approved dosage), two months | Santen Pharmaceutical Co., Ltd.; Level of the institution：, Santen Pharmaceutical Co., Ltd. | Primary Open Angle Glaucoma, Primary Angle Closure Glaucoma, Ocular Hypertension | | | | |
ChiCTR-OIC-17011980: Effectiveness and safety of tafluprost 0.0015% mono-therapy in Chinese patients with primary open-angle glaucoma and ocular hypertension |
|
|
| Not yet recruiting | 4 | 300 | | Treated with one drop of tafluprost 0.0015% Ophthalmic Solution in the affected eye(s) in the evening once daily | Eye & ENT Hospital of Fudan University; Santen Pharmaceutical (China) Co., Ltd., Santen Pharmaceutical (China) Co., Ltd. | primary open-angle glaucoma and ocular hypertension | | | | |
2014-004442-10: Investigation of intraocular pressure and tolerability of Bimatoprost 0.1% and Tafluprost Unit Dose Preservative Free 15 microgram/ml. |
|
|
| Ongoing | 4 | 67 | Europe | Eye drops, solution, Eye drops, suspension in single-dose container, Preservatived Bimatoprost, Lumigan 0.1 mg/ml, Tafluprost Unit Dose Preservative Free | UZ Leuven, Allergan | Ocular hypertension and glaucoma, Ocular hypertension and glaucoma, Diseases [C] - Eye Diseases [C11] | | | | |
2014-000404-10: Effectiveness in the ocular pressure, tolerability and influence in the ocular surface of bimatoprost and tafluprost pod in patients with glaucoma and ocular hipertension Eficacia sobre la presión intraocular, tolerancia e influencia sobre la superficie ocular del Bimatoprost monodosis y Talfuprost monodosis en pacientes con glaucoma e hipertension ocular |
|
|
| Ongoing | 4 | 60 | Europe | Bimatoprost, Tafluprost, Eye drops | Hospital Clinico San Carlos, Allergan Inc | Glaucoma andr ocular hypertension Glaucoma e hipertension ocular, Ocular hypertension Tension ocular alta, Diseases [C] - Eye Diseases [C11] | | | | |
ChiCTR-OPC-17013229: The Diurnal and Nocturnal Effect of Tafluprost on Intraocular Pressure and Ocular Perfusion Pressure |
|
|
| Not yet recruiting | 4 | 40 | | local eye drop | The Second Affiliated Hospital of Harbin Medical University; The Second Affiliated Hospital of Harbin Medical University, santen pharmaceutical china,Co.,Ltd. | glaucoma | | | | |
2019-004841-34: Laser treatment versus eye drops as initial treatment in exfoliation glaucoma Laserhoito verrattuna silmätippoihin eksfoliaatio glaukooman ensimmäisenä hoitona |
|
|
| Ongoing | 4 | 112 | Europe | Eye drops, solution in single-dose container, Taflotan | Mika Harju, Glaukooma tukisäätiö LUX | Glaucoma Glaukooma, Glaucoma Glaukooma, Diseases [C] - Eye Diseases [C11] | | | | |
| Recruiting | 4 | 48 | | Use bimatoprost ;Use travoprost ;Use latanprost ;Use tafluprost | West China Hospital of Sichuan University; West China Hospital of Sichuan University, 2019 West China Clinical Medical College of Sichuan University /West China Hospital Resident/Specialist Scientific Research Fund | Glaucoma | | | | |
